SALADINI FRANCESCO | Elenco docenti

Giammarino, F., Paletti, C., Bartolini, N., Fiaschi, L., Biba, C., Varasi, I., et al. (2025). Combined doravirine and islatravir cooperate to inhibit NRTI and NNRTI resistant HIV-1 in vitro. ANTIVIRAL RESEARCH, 239 [10.1016/j.antiviral.2025.106157]. - dettaglio
Fiaschi, L., Biba, C., Varasi, I., Bartolini, N., Paletti, C., Giammarino, F., et al. (2024). In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants. VIRUSES, 16(2), 1-12 [10.3390/v16020168]. - dettaglio
Monti, B., Soria, A., Saladini, F., Lapadula, G., Squillace, N., Giammarino, F., et al. (2024). Regaining virological suppression in a woman living with a six-class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests. JOURNAL OF MEDICAL VIROLOGY, 96(8) [10.1002/jmv.29832]. - dettaglio
Biba, C., Fiaschi, L., Varasi, I., Paletti, C., Bartolini, N., Zazzi, M., et al. (2024). A Comparison of Sanger Sequencing and Amplicon-Based Next Generation Sequencing Approaches for the Detection of HIV-1 Drug Resistance Mutations. VIRUSES, 16(9) [10.3390/v16091465]. - dettaglio
Mazzitelli, M., Pontillo, D., Clemente, T., Di Biagio, A., Cenderello, G., Rusconi, S., et al. (2024). Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 79(9), 2163-2169 [10.1093/jac/dkae190]. - dettaglio

Tutte le pubblicazioni